ConCallIQ
Go Pro
Home › Management Profiles › Ravi Kara
R

Ravi Kara

Chief Financial Officer

1 company 1 earning tracked 1 quote

Promise Delivery Record

📊
Scorecard building

ConCallIQ tracks whether management promises made on earnings calls are delivered. Data for Ravi Kara is being built as historical quarters are processed. Check back next quarter.

Notable Quotes

Excluding injectables related startup cost and cost associated with our US subsidiary, EBITDA margins remain in the range of 40% for Q3 and 9M FY26.
Ravi Kara · Concord Biotech Q3 FY26

Earnings Appearances

Concord Biotech · Q3 FY26
Read earnings analysis →